Mesoblast Limited vs Sea Limited — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Sea Limited trades at $129.92 (market cap $80.55B). The key difference: Sea Limited is far larger — about 36.4× Mesoblast Limited's market cap. Which is the better fit depends on your goals.
| MESO | SE | |
|---|---|---|
Market Cap | $2.21B | $80.55B |
Sector | Technology | Media |
52-Week High | $20.96 | $196.50 |
52-Week Low | $12.88 | $78.16 |
Enterprise Value | $2.21B | $75.58B |
Trailing returns across standard periods
Latest headlines on both assets
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →Sea Limited offers information technology services. The Company provides online personal computer and mobile digital content, e-commerce, and payment platforms. Sea serves customers worldwide.
Read more on SE →